Nurse Practitioner, Family · Orange City, FL
NPI
1609327337
Since 2016
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2885 Wellness Ave
Orange City, FL, 32763
Phone (386) 917-7627
Groups this clinician bills Medicare through
Medicare paid, 2024
$36K
514 services
Medicare patients, 2024
230
Average age 73
Drug cost, 2024
$4.8M
8,454 prescriptions
Company payments, 2025
$16.09
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maria Benavidez was code 99214 (office e&m - established), 376 times for 196 patients. In total Maria Benavidez billed 514 services in 8 codes, and Medicare paid $36K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-05-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 376 | 196 | $76.75 | $29K |
| 99212 Office E&M - Established | Office | 49 | 38 | $35.83 | $1,756 |
| 99213 Office E&M - Established | Office | 35 | 32 | $55.59 | $1,946 |
| 99204 Office E&M - New | Office | 26 | 26 | $105.78 | $2,750 |
| 83036 Blood Count | Office | 23 | 23 | $9.11 | $209 |
By year: 2022 $28K for 421 services; 2023 $40K for 582 services; 2024 $36K for 514 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 23 | 23 | $9.11 | $209 |
Medicare prescription drug claims, 2024
In 2024, the drug Maria Benavidez prescribed most often to Medicare patients was Levothyroxine Sodium, with 772 prescriptions and refills. In total Maria Benavidez wrote 8,454 Medicare prescriptions that cost $4.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 772 | 2,094 | 224 | $6,571 |
| Ozempic Semaglutide | 754 | 1,428 | 204 | $1.4M |
| Metformin Hcl Generic | 538 | 1,552 | 184 | $3,677 |
| Metformin Hcl Er Metformin Hcl | 522 | 1,529 | 182 | $5,260 |
| Jardiance Empagliflozin | 466 | 1,167 | 150 | $672K |
| Mounjaro Tirzepatide | 331 | 531 | 91 | $574K |
| Glipizide Er Glipizide | 286 | 812 | 87 | $5,215 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 260 | 726 | 123 | $32K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 254 | 664 | 84 | $37K |
| Tresiba Flextouch U-100 Insulin Degludec | 216 | 601 | 87 | $165K |
| Glipizide Generic | 210 | 605 | 78 | $1,617 |
| Trulicity Dulaglutide | 207 | 361 | 71 | $349K |
| Glimepiride Generic | 178 | 508 | 61 | $1,228 |
| Farxiga Dapagliflozin Propanediol | 169 | 373 | 46 | $205K |
| Atorvastatin Calcium Generic | 157 | 442 | 51 | $1,406 |
Brand drugs: 4,374 claims; generic drugs: 3,242 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maria Benavidez $16.09 ($16.09 in general payments such as food, travel and fees) from 1 company. The largest payer was Insulet Corporation with $16.09.
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation PODD | 1 | $16.09 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.